A new drug developed by Australian researchers has shown promising results in reducing sepsis in a Phase II clinical trial involving 180 patients. The carbohydrate-based treatment works by calming a ...

Sexual dysfunction was identified among nearly one-half of adults with systemic vasculitis in a cross-sectional study published in the Journal of Clinical Rheumatology, with older age and female sex ...

A crackdown on problems with fairness and safety is achieving results, including a big drop in the number of sick patients ...

MSC-derived extracellular vesicles provide a novel cell-free nanotherapeutic strategy for hepatorenal syndrome and reveal a ...

Objective: to evaluate the performance of qSOFA in identifying deterioration in patients with COVID-19. Method: retrospective cohort study conducted between February and August 2020 in the Emergency ...

The content creator speaks to PEOPLE from a hospital bed in the ICU, where he says his heart’s ejection fraction is between 15 and 20%, considered very severe congestive heart failure “I’m really ...

Sepsis-induced multiple organ dysfunction syndrome is the leading cause of mortality among patients with sepsis. Its pathophysiological mechanisms encompass various factors, including dysregulated ...

Introduction: Noncardiac organ failure is a frequent complication in non–acute myocardial infarction (non-AMI) cardiogenic shock (CS), yet its impact on in-hospital outcomes remains understudied.

CN Bio has launched PhysioMimix ® Core, an integrated Organ-on-a-chip (OOC) platform that supports single-organ, multi-organ, and higher-throughput configurations within one system. The instrument is ...